HOME >> BIOLOGY >> NEWS
Study explores gene transfer to modify underlying course of Alzheimer's disease

Investigators at Rush University Medical Center have successfully initiated a new technique that uses gene therapy to deliver nerve growth factor into regions of the brain where neurons are degenerating, in order to prevent cell death and reverse cell atrophy, two hallmarks of Alzheimer's disease. If successful, this could be a major step toward modifying the course of the disease. Rush is the only center in this study.

The new technique uses CERE-110 as the gene therapy agent. CERE-110 carries the Nerve Growth Factor (NGF) gene encased in a harmless viral coating, which protects the gene and facilitates its delivery to brain cells. The active part of the drug is the NGF gene, the human DNA strand that codes for the NGF protein, a natural substance that exerts positive effects on brain cells. A key objective of the study is to deliver the CERE-110 directly to the part of the brain that is almost universally affected by Alzheimer's disease, the basal forebrain, and not to other parts of the brain where it may cause side effects.

The new drug, CERE-110, is being used by researchers at Rush as part of a Phase I study to evaluate its safety and tolerability using two different doses. Memory and cognitive function will also be assessed regularly during the two-year period of the study. Six to 12 subjects with mild to moderate Alzheimer's disease, based on the specific cognitive tests used to classify the disease stage, will be enrolled in the study.

The first patient in the study was treated on July 27. Dr. David Bennett and Dr. Zoe Arvanitakis of the Rush Alzheimer's Disease Center are the co-principal investigators. Bennett is director of the center. Ceregene, Inc., based in San Diego, (a minority owned subsidiary of Cell Genesys, Inc.) the developer and manufacturer of CERE-110, is funding the study.

Neurosurgery is required to precisely inject the drug into the nucleus basalis of Meynert on both sides of the brain. Dr. Roy Ba
'"/>

Contact: John Pontarelli
jpontare@rush.edu
312-942-5949
Rush University Medical Center
21-Sep-2004


Page: 1 2 3 4

Related biology news :

1. Study: Emission of smog ingredients from trees is increasing rapidly
2. Study reveals why eyes in some paintings seem to follow viewers
3. Study by Israeli scientists provides insight on DNA code
4. Study reveals first genetic step necessary for prostate cancer growth
5. Study of flu patients reveals virus outsmarting key drug
6. Study in Science reveals recreational fishing takes big bite of ocean catch
7. Study suggests cell-cycle triggers might be cancer drug targets
8. Study narrows search for genes placing men at increased risk for prostate cancer
9. Study links high carbohydrate diet to increased breast cancer risk
10. Study explains spatial orientation differences between sexes
11. Study suggests humans can speed evolution

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/6/2020)... ... May 06, 2020 , ... Sickle Cell Disease Association ... technology company dedicated to improving the quality, safety, efficacy and cost of red blood ... SCDAA deliver on its mission and meet its goals. In 2020 Hemanext will collaborate ...
(Date:5/1/2020)... (PRWEB) , ... April 30, 2020 , ... ... today announced an alliance with Corritori Consulting Inc., a biopharmaceutical and regulatory services ... pharmaceutical and companion diagnostics industries. Flagship and Corritori are taking a collaborative approach ...
(Date:4/30/2020)... ... April 28, 2020 , ... Pebble Labs USA Inc. , ... agriculture and aquaculture with the mission of improving global food security, announced today that ... ' Next Heroes in Food- and Ag-Tech ' virtual event, a global initiative to ...
Breaking Biology News(10 mins):
(Date:4/22/2020)... CHESTER, Ohio (PRWEB) , ... April 21, 2020 ... ... of Biophen™ FXIII chromogenic method for determination of FXIII. , Aniara Diagnostica, a ... strengthened its commitment to meeting today’s highest standards for product quality and cost-efficient ...
(Date:4/18/2020)... ... April 17, 2020 , ... NeuroFlow ... Innovation Research (SBIR) program to support the expansion of its digital health platform ... which conducts a rigorous merit-based review process, adds to NeuroFlow’s recent government ...
(Date:4/7/2020)... (PRWEB) , ... April 06, 2020 , ... ... process solutions for the life sciences industry, has announced the release of at-home ... quickly, our top priority is the health and safety of our employees as ...
(Date:4/1/2020)... Texas (PRWEB) , ... March 30, 2020 , ... ... (APMD) and telehealth developer Reliant Immune Diagnostics (RID), formed earlier this year to ... COVID-19 pandemic by creating in-home tests for COVID-19. Company officials are currently?awaiting an ...
Breaking Biology Technology:
Cached News: